Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Arvinas to Present at 6th Annual Guggenheim Biotechnology Conference | ||
By: GlobeNewswire - 01 Feb 2024 | Back to overview list |
|
NEW HAVEN, Conn., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that Ron Peck, M.D., Chief Medical Officer, and Randy Teel, Ph.D., Senior Vice President, Corporate and Business Development will participate in a fireside chat at the 6th Annual Guggenheim Biotechnology Conference on Wednesday, February 7 at 10:30 a.m. ET in New York. A live audio webcast of the presentation will be available here and under “Events and Presentations” of the Investors and Media section of the Company’s website. About Arvinas Contacts Investors: Media: |
||
|
||
Copyright 2024 GlobeNewswire | Back to overview list |